Expert consensus on GD2 antibody dinutuximab-β in the treatment of neuroblastoma
Collaborative Group on GD Monoclonal Antibody in the Treatment of Neuroblastoma
Journal of Clinical Pediatrics . 2022, (1): 14 -20 .  DOI: 10.12372/jcp.2022.21e1685